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Abstract
MicroRNAs are a class of small non-protein coding RNAs that play an important role in the regulation of gene expression.
Most studies on the identification of microRNA-mRNA pairs utilize the correlation coefficient as a measure of association.
The use of correlation coefficient is appropriate if the expression data are available for several conditions and, for a given
condition, both microRNA and mRNA expression profiles are obtained from the same set of individuals. However, there are
many instances where one of the requirements is not satisfied. Therefore, there is a need for new measures of association to
identify the microRNA-mRNA pairs of interest and we present two such measures. The first measure requires expression
data for multiple conditions but, for a given condition, the microRNA and mRNA expression may be obtained from different
individuals. The new measure, unlike the correlation coefficient, is suitable for analyzing large data sets which are obtained
by combining several independent studies on microRNAs and mRNAs. Our second measure is able to handle expression
data that correspond to just two conditions but, for a given condition, the microRNA and mRNA expression must be
obtained from the same set of individuals. This measure, unlike the correlation coefficient, is appropriate for analyzing data
sets with a small number of conditions. We apply our new measures of association to multiple myeloma data sets, which
cannot be analyzed using the correlation coefficient, and identify several microRNA-mRNA pairs involved in apoptosis and
cell proliferation.
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Introduction
MicroRNAs (miRNAs) are small (,22 nt) non-protein coding
RNAs that are involved in the post-transcriptional regulation of
mRNA expression. The miRNAs are of immense biological
significance, e.g. changes in miRNA expression have been linked
to cancer [1–4], and, over the past two decades, numerous studies
have focused on miRNAs. The studies on miRNAs can be broadly
grouped into two categories – identification of miRNAs as
molecular markers for better prognosis/diagnosis [5,6] and under-
standing the role of miRNAs in transcription regulation [7–11]. In
this paper, we focus on the latter category and introduce new
methods for obtaining insights into a miRNA’s regulatory role.
The identification and validation of a regulatory miRNA
requires a knowledge of its target mRNAs and, initially,
computational algorithms such as TargetScanS [12], PicTar [13]
andmiRanda[14] were used to obtainthe putative miRNA-mRNA
pairs based on sequence data. Although, for every miRNA, these
algorithms suggested a potential pairing with several hundred
mRNAs, the number of genuine pairs was much lower (<50%)
[15]. Even if a pair is genuine, it may not be of interest in a
particular biological condition because the regulatory miRNAs vary
from one condition to another. For example, the miRNAs that are
regulatory in lung cancer may not be regulatory in pancreatic
cancer. Therefore, the computational algorithms are not sufficient
to obtain the pairs of interest under different biological conditions.
Over the past decade, several methods [16–19] have been
developed that combine the results of computational algorithms
with mRNA expression data. While these methods are suitable for
identifying the potentially regulatory miRNAs, they cannot be
used to obtain the miRNA-mRNA pairs for experimental
validation. This is because a miRNA-mRNA pair is of potential
biological interest only if there is an association between the
expression levels of the relevant miRNA and mRNA. Conse-
quently, integrative methods that combine the results of target-
prediction algorithms with both mRNA and miRNA expression
data have become popular. While some of these integrative
methods focus on the identification of miRNA-mRNA pairs
[20–25], others focus on the identification of miRNA-mRNA
modules, i.e. groups of miRNAs that co-regulate groups of
mRNAs [26–30]. Broadly speaking, the integrative methods
employ a three step procedure as described below:
1. Identification of differentially expressed (DE) miRNAs and
mRNAs: An expression data set corresponds to multiple
conditions and one of these, e.g. healthy state, is selected as the
reference. Next, the miRNAs and mRNAs that are DE, with
respect to reference, in at least one of the conditions are
identified.
2. Selection of putative miRNA-mRNA pairs: A miRNA-target
prediction algorithm is used to obtain the DE mRNAs that are
putative targets of one or more of the DE miRNAs.
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The miRNA and mRNA expression profiles are used to obtain
the statistical significance of the pairs identified in Step 2.The
statistically significant pairs are considered to be of potential
biological interest and are usually selected for further
experimental studies or validation. Unless specified otherwise,
in the rest of this paper, significance implies statistical
significance.
The identification of statistically significant pairs (Step 3) is a
challenging task and has two components – the selection of an
appropriate association measure and the determination of its
significance. Most studies on the identification of miRNA-mRNA
pairs of interest utilize the correlation coefficient [20,22–25,27] as
a measure of association and several methods have been proposed
to obtain its significance. Lionetti et al. [20] used the correlation
coefficient to rank the miRNA-mRNA pairs such that the pair
with the strongest negative correlation was ranked one. Next, the
authors chose an arbitrary cut-off of 3% and considered the top
3% of the pairs (in terms of rank) to be of potential biological
significance. A more formal approach for identifying the miRNA-
mRNA pairs of biological interest is based on a test of significance.
If the distribution of correlation coefficients is known, then this
distribution can be used to perform the significance test, e.g.
Gutierrez et al. [24] performed a test of significance under the
assumption that the distribution was bivariate normal. If the
distribution is unknown, then a permutation test [25,27] is more
appropriate for obtaining the significance of association.
The use of correlation coefficient as an association measure is
appropriate only if every individual in the study is used to obtain
both miRNA and mRNA expression profiles. In other words, the
use of correlation coefficient requires the miRNA and mRNA
expression data to be matched. Moreover, the matched data have
to be available for several biological conditions. For a small
number of conditions, the correlation coefficient-based measure
can be very noisy and for the extreme case where the number of
conditions is just two, this measure is not meaningful. Therefore,
there is a need for new measures of association to identify the
miRNA-mRNA pairs of interest using a small number of
biological conditions. To this end, we introduce an association
measure that enables the identification of significant miRNA-
mRNA pairs using matched expression data for just two
conditions.
The number of biological conditions can be increased by
combining multiple miRNA and mRNA studies. In theory, the
integration of data from multiple studies increases the number of
samples per condition and the total number of conditions, thereby
adding power to the miRNA-mRNA association measure. Many
of the microarray data sets in the Gene Expression Omnibus [31]
repository correspond to either miRNA or mRNA expression.
Consequently, the miRNA and mRNA data are unmatched and,
even for a large number of biological conditions, the correlation
coefficient cannot be used for measuring association. We present a
novel association measure for analyzing unmatched data that
correspond to a large number of conditions. In the next section, we
apply the new association measures to two multiple myeloma
(MM) data sets and identify several miRNA-mRNA pairs involved
in apoptosis and cell proliferation.
Results
We illustrate the applicability of the new association measures
using two independently generated MM data sets. The first data
set, henceforth referred to as the Lionetti data set [20], comprised
healthy donors and MM patients stratified into five groups – TC1
to TC5 – based on TC [32] classification. The second data set,
henceforth referred to as the Gutierrez data set [24], comprised
healthy donors and MM patients with the following cytogenetic
characteristics – normal FISH, t(11;14) (with or without RB
deletion), t(4;14) (with or without RB deletion), and RB deletion as
a unique abnormality. The two data sets were normalized as
described in the Materials and Methods section. In the rest of this
paper, RB deletion implies ‘‘RB deletion as a unique abnormality’’
and every MM group represents a biological condition of interest.
Differentially expressed miRNAs and mRNAs
We considered a miRNA or mRNA to be DE in a biological
condition of interest if the difference in average expression
between the MM group and healthy individuals was statistically
significant (refer Materials and Methods section).The Lionetti data
set had five MM groups (i.e. TC1 to TC5) and the number of
miRNAs and mRNAs that were DE in at least one of the five MM
groups was 75 and 1024, respectively. Similarly, for the Gutierrez
data set, the number of miRNAs and mRNAs that were DE in at
least one of the four MM groups was 133 and 3486, respectively.
The correlation coefficient is an appropriate measure of
association between miRNAs and mRNAs when the number of
biological conditions is large. Since the Lionetti and Gutierrez data
sets comprised fewer than six conditions, an identification of the
significant miRNA-mRNA pairs using these data sets required the
use of new association measures (Figure 1).
Unmatched data association measure
The unmatched data (UD) association measure requires
miRNA and mRNA expression profiles for several biological
conditions and these conditions can be obtained by combining
multiple data sets. We merged the Lionetti and Gutierrez data sets
to obtain a ‘‘Master’’ data set comprising nine MM groups. The
Master data set contained miRNAs and mRNAs that were DE in
at least one of the groups (with respect to healthy individuals) and
common to both Lionetti and Gutierrez data sets. Thus, we
obtained a total of 120 miRNAs and 3260 mRNAs.
We use the notation ‘‘FC-value’’ to denote the difference
between the average expression (miRNA or mRNA expression) in
healthy donors and a MM group. We transformed the FC-values
into +1, 21, or 0 using a discretization step (refer Materials and
Methods section) and these transformed values are henceforth
referred to as ‘‘discretized FC-values’’. The discretized FC-value of
21 corresponds to an overexpression of miRNA/mRNA in
healthy donors with respect to MM patients. Similarly, the
discretized FC-value of +1 corresponds to an overexpression in
MM patients with respect to healthy donors.
Once the discretized FC-values were obtained for the miRNAs
and mRNAs in the Master data set, we determined the putative
miRNA-mRNA pairs using TargetScanS. Although there are
numerous miRNA-target prediction algorithms, they have similar
sensitivity values [15] and we chose one of the commonly used
algorithms for downstream analysis (refer Appendix S1 for an
analysis based on miRBase). Of the 391,200 (120 miRNAs63260
mRNAs) possible pairs, 6142 were predicted by TargetScanS. For
each of the 6142 pairs, we used the discretized FC-values to test
the null hypothesis that a change in mRNA expression is
independent of a change in miRNA expression. We adjusted the
p-values for multiple comparison using the Benjamini-Hochberg
(BH) correction [33]. If the adjusted p-value was less than 0.05,
then we rejected the null hypothesis and considered the association
between the miRNA-mRNA pair to be of potential biological
significance. We identified 40 of the 6142 pairs as significant and
Association Measure for Unmatched and Matched Data
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mRNAs (Table S1).
We have previously shown using luciferase reporter assays that
miRNAs can negatively regulate the translation of mRNA to
protein [34] and similar results have been reported in other studies
[9,35]. Therefore, if the FC-value for a miRNA is positive (resp.,
negative), then the FC-value for the target mRNA must be
negative (resp., positive). While the UD association measure can
be used to identify miRNA-mRNA pairs with FC-values in the
opposite direction or the same direction, in this paper we consider
a pair to be significant only if the miRNA and mRNA FC-values
are in the opposite direction for at least one of the biological
conditions. In fact, for the master data set, some of the significant
pairs had miRNA and mRNA FC-values in the opposite direction
for more that one condition (Figure 2). For example, the pair hsa-
miR-191:CCND2 had FC-values in the opposite direction for
TC4 and RB deletion. Similarly, the pair hsa-miR-205:ESRRG
had FC-values in the opposite direction for TC1 and TC4.
For a given condition, the calculation of miRNA and mRNA
FC-values and, hence, the discretized FC-values, does not require
the miRNA and mRNA expression to be obtained from the same
set of individuals. Since the UD association measure only requires
discretized FC-values as input, it is not dependent on the miRNA
and mRNA data being matched.
Matched data association measure
Instead of evaluating multiple MM groups to identify the
significant miRNA-mRNA pairs, we could compare a MM group
to healthy individuals and determine the miRNA-mRNA pairs of
interest in the relevant MM group (Figure 1). Since the UD
Figure 1. Identification of significant miRNA-mRNA pairs using association measures based on unmatched and matched data.
doi:10.1371/journal.pone.0029612.g001
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Appendix S2 for an explanation), we utilized the matched data
(MD) association measure.
The MD association measure considers a miRNA-mRNA pair to
be of potential biological significance if the change in miRNA
e x p r e s s i o np r o d u c e sac h a n g ei nm R N Ae x p r e s s i o ni nt h eo p p o s i t e
direction and the magnitude of change is higher than that by chance.
The MD association measure requires the changes in miRNA and
mRNA expression for the same set of individuals and is not applicable
to unmatched data. Therefore, we analyzed the MM groups
corresponding to Lionetti and Gutierrez data sets separately (Figure 1).
For the purpose of illustration, instead of analyzing all the nine
MM groups, we focused on the two MM groups corresponding to
the largest number of samples (or patients). For the Lionetti data
set, the maximum number of samples was 10, which corresponded
to patients with TC2 classification. For the Gutierrez data set, the
maximum number of samples was 14, which corresponded to
patients with RB deletion.
We use the notation ‘‘CE-value’’ to denote the change in
miRNA/mRNA expression of a MM patient with respect to
healthy donor. To identify the miRNA-mRNA pairs of potential
biological significance in the RB deletion MM group, we first
obtained the miRNA and mRNA CE-values for each of the
10 MM patients. Next, we provided these CE-values as input to
the MD association measure and tested the null hypothesis that the
change in mRNA expression is independent of a change in
miRNA expression. We adjusted the p-values for multiple
comparisons using the BH correction. If the adjusted p-value
was less than 0.05 we rejected the null hypothesis and considered
the miRNA-mRNA pair to be significant. Of the 6142 putative
miRNA-mRNA pairs returned by TargetScanS, we identified 406
pairs as significant. These pairs corresponded to 47 unique
miRNAs and 131 unique mRNAs (Table S2). Similarly, for an
analysis involving TC2 patients, 187 of the 6142 pairs were
observed to be significant. These pairs corresponded to 18 unique
miRNAs and 85 unique mRNAs.
Figure 2. Significant miRNA-mRNA pairs obtained using unmatched data. The labels on the X-axis correspond to biological conditions and
the labels on the Y-axis correspond to miRNA-mRNA pairs. Blue indicates that the miRNA-mRNA pair was statistically significant in the relevant
condition.
doi:10.1371/journal.pone.0029612.g002
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measure with those obtained using correlation coefficient, we
focused on patients with RB deletion. For every miRNA-mRNA
pair that was predicted by TargetScanS, we used the miRNA and
mRNA CE-values to obtain the correlation. Next, we performed a
permutation test (refer Materials and Methods section) for the null
hypothesis that the association between a miRNA and mRNA was
nothigherthan that bychance.Weadjustedthe p-value formultiple
comparisons using the BH correction and identified 19 of the 6142
miRNA-mRNA pairs as significant (adjusted p-value,0.05). The
number of miRNA-mRNA pairs that were identified as significant
using both correlation coefficient and MD association measure was
just3. For a miRNA-mRNA pair to be genuine, the average change
in mRNA expression must be in the opposite direction to that of the
miRNA. For example, if the average CE-value is positive for a
miRNA, then the average CE-value must be negative for the target
mRNA. Figure 3 shows the relationship between miRNA hsa-miR-
320 and two of its putative targets, ATRX and CAMSAP1L1; the
average CE-values were 22.53, 21.53, and 1.26, respectively.
Though the pair hsa-miR-320:ATRX was identified as
significant using the correlation coefficient, the average CE-value
was negative for both miRNA and mRNA. Therefore, ATRX
cannot be considered a genuine target of hsa-miR-320. In
contrast, the directions of average CE-values for hsa-miR-320
and CAMSAP1L1 were opposite, suggesting a potential targeting
of CAMSAP1L1 by hsa-miR-320. In fact, the pair hsa-miR-
320:CAMSAP1L1 was identified as significant using the correla-
tion coefficient as well as the MD association measure.
Concordance in results obtained using MD and UD
association measures
While the MD association measure is suitable for analyzing one
MM group at a time, the UD association measure is appropriate
for analyzing several MM groups simultaneously. We analyzed
nine MM groups using the UD association measure and two of
these (RB deletion and TC2) were also analyzed using the MD
association measure. For these two MM groups, we determined
the overlap between the significant pairs identified using the two
measures. As mentioned earlier, the UD association measure
returned 40 significant pairs and each of these pairs corresponded
to miRNA and mRNA FC-values in the opposite direction for at
least one of the nine MM groups. We observed that 28 of the 40
pairs had RB deletion as one of the biological groups with FC-
values in the opposite direction. The MD association measure
returned 406 significant miRNA-mRNA pairs for RB deletion and
these included the 28 pairs obtained using UD. Similarly, eight of
the 40 significant pairs obtained using UD were associated with
TC2 and these eight pairs were also identified using MD.
Figure 3. Relative expression levels of hsa-miR-320 and two of its predicted targets in samples with RB deletion.
doi:10.1371/journal.pone.0029612.g003
Association Measure for Unmatched and Matched Data
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To illustrate the biological significance of the results obtained
using UD and MD association measures, we focused on the MM
group with the largest sample size, i.e. patients with RB deletion.
Of the 406 significant miRNA-mRNA pairs obtained using the
MD association measure, some were identified as significant in the
Gutierrez study as well. These included hsa-miR-320a:MLLT3,
hsa-miR-20a:CDKN1A, hsa-miR-20a:FURIN, hsa-miR-19b:IGF1,
hsa-miR-15a:CCND2, hsa-miR-10b:KLF11, hsa-miR-19a:IGF1,
and hsa-miR-19a:CCND2.
Among the miRNAs identified as significant many have
previously been shown to be dysregulated in MM, e.g. hsa-miR-
135b, -196a, -19a, -19b, -205, -214, -223, -320, -373, -375, -485-
5p and -520b [24,36–38]. Of significance is the identification of
miR-19 family and in particular hsa-miR-19a and -19b; these two
miRNAs have been linked to B cell neoplasms, including MM and
have recently been directly implicated in MM pathogenesis
[39,40].
The 406 significant pairs corresponded to 131 unique mRNAs
and a gene ontology (GO) analysis showed that many of these
mRNAs were associated with apoptosis, cell proliferation and
transcription regulation (Table 1). Overall, 57 miRNA-mRNA
pairs were associated with apoptosis, 75 pairs were associated with
transcription regulation, and 82 pairs were associated with cell
proliferation (Table S3).
Some of the genes of interest were SOCS3, JUND, and Pellino
homolog 1 (PELI1) (Figure 4). Our MD association measure
suggested that the anti-apoptotic gene SOCS3 was regulated by
four miRNAs, including hsa-mir-19a and -19b. This gene is
involved in the IL-6 signaling pathway which is important in
myeloma cell survival [41]. The gene JUND has been shown to
modulate the development of drug resistance in a majority of
patients on Bortezomib-based anti-myeloma therapy [42]; three of
the miRNAs identified in the original study as regulators of JUND
were predicted using our MD model. The gene PELI1 has recently
been shown to be involved in hsa-mir-21 mediated control of NF-
kB signaling [43].
Among the 28 miRNA-mRNA pairs that were identified using
both MD and UD, one of the genes of interest was cyclin D2
(CCND2). The 28 pairs corresponded to 22 unique miRNAs and
16 of these targeted CCND2. The cyclin D genes are regularly
involved in chromosomal translocations in MM and the expression
levels of these cyclins in myeloma tumors is extremely high in
relation to normal proliferating peripheral blood cells [44]. A
suppression of the expression of CCND2 using RNA interference
(a method similar to miRNA inhibition) in myeloma cells inhibited
proliferation and was progressively cytotoxic [45].
Discussion
The new association measures enable the identification of
miRNA-mRNA pairs of potential biological interest using
microarray data sets that cannot be analyzed using the correlation
coefficient (Table 2). Thus, our association measures extend the
scope of data sets that can be used to generate new hypotheses
and/or design new experiments.
The MD association measure requires data for just two
conditions and is suitable for analyzing pilot studies, where a
small number of conditions are evaluated. The results obtained
using the pilot studies can be used to design experiments for a
comprehensive miRNA-mRNA analysis without having to effec-
tively repeat the profiling experiments. Instead of a pilot study, one
may utilize the previously published microarray profiling studies to
identify the miRNA-mRNA pairs for further experimentation.
However, many published studies comprise a small number of
biological conditions (#5) and do not include the expression levels
of both miRNAs and mRNAs, e.g. [46–48]. The UD association
measure, unlike the existing measures of association, can be used
to co-analyze the independent miRNA and mRNA studies and
identify the miRNA-mRNA pairs of potential interest. Thus, our
UD and MD association measures allow researchers to obtain
greater confidence in candidate miRNA-mRNA pairs before
embarking on time-consuming and costly downstream experi-
ments. For example, our analysis of the MM data sets supports a
downstream experiment centered around the control of SOCS3
by the hsa-miR-19 family.
The discretization of expression data, prior to the calculation of
UD-based association measure, enables us to focus on the
directions of change in miRNA and mRNA expression (with
respect to a reference) rather than the magnitudes of change. An
advantage of this approach is that the discretized expression
profiles are comparable across all microarray platforms. For
example, the range of expression values obtained using Taqman
low density arrays is very different from that measured using
Agilent microarrays. Also, under different conditions the quanti-
tative level of a miRNA’s regulatory effect may vary. Therefore, if
the actual expression values are used, then a UD-based method
that adjusts for platform-specific and condition-specific differences
will be needed; to the best of our knowledge, such methods are not
Table 1. Number of mRNAs associated with different
biological processes in the RB deletion group.
Process Number
Apoptosis 24
Signaling pathway 23
Transcription regulation 22
Cell proliferation 17
Cell cycle 8
Cell differentiation 5
doi:10.1371/journal.pone.0029612.t001
Figure 4. Network diagram comprising miRNAs that potentially
regulate genes SOCS3, JUND, and PELI1.
doi:10.1371/journal.pone.0029612.g004
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where multiple conditions are evaluated. If the number of
conditions is just two, then this association measure is inappro-
priate. However, there is no known solution for this limitation of
the UD association measure.
While the UD association measure does not require miRNA
and mRNA data from the same individual, the data must
correspond to the same set of biological conditions. If there are
multiple miRNA/mRNA data sets that correspond to the same set
of biological conditions, then a representative data set may be
selected prior to the estimation of association. This selection could
be based on a measure of agreement, such as Cohen’s kappa [49],
between the data sets. Once all the pairwise agreements between
the miRNA/mRNA data sets have been obtained, the data set
with the highest average agreement can be selected as the
representative data set.
Our measures of association can be used to identify miRNA-
mRNA modules, i.e. clusters of miRNAs that regulate clusters of
mRNAs. There are instances where two or more miRNAs
collectively regulate multiple mRNAs and, in recent times, some
methods have been proposed for obtaining such modules
[27,28,30]. Since these module-identification methods utilize the
correlation coefficient as the measure of association, they require
matched miRNA-mRNA data for multiple conditions. Our UD
association measure, unlike the correlation coefficient, enables an
analysis of unmatched miRNA and mRNA data sets. Conse-
quently, the UD association measure extends the scope of data sets
that can be analyzed using the module-identification methods.
We showed that even when the miRNA and mRNA expression
data are matched, the use of correlation coefficient may not be
appropriate. Though the correlation coefficient is a measure of
association between miRNA and mRNA expression, it is
independent of the average CE-values. Consequently, the
correlation coefficient may identify a miRNA-mRNA pair as
significant even when the average CE-value is negative (or
positive) for both miRNA and mRNA. In our analysis of MM
patients with RB deletion, hsa-miR-320:ATRX was identified as
significant using the correlation coefficient even though the
average CE-value was negative for both miRNA and mRNA.
Our MD association measure assumes that if a miRNA targets
an mRNA, then the change in mRNA expression due to a change
in miRNA expression must be significant. However, there may be
instances where several miRNAs cooperatively regulate an mRNA
and the individual effect of a miRNA on mRNA expression is low.
Our model can be extended to consider the coregulation of an
mRNA by multiple miRNAs. Such a model may provide new
insights into the miRNA-based regulatory mechanism.
Materials and Methods
Unmatched data
We first describe the method for identifying significant miRNA-
mRNA pairs under the assumption that the miRNA and mRNA
expression profiles are not matched. Even though we do not
assume the expression profiles to be matched, we require the
expression profiles to correspond to the same biological groups,
e.g. the same MM groups. First, we select one of the biological
groups in the data set, e.g. healthy donors, as the reference. Next,
we test the null hypothesis that the average expression of a
miRNA/mRNA in a MM group is the same as that for reference.
If the p-value for the hypothesis, after adjusting for multiple
comparisons, is less than 0.05, then we consider the miRNA/
mRNA to be DE in the relevant MM group.
(i) Measure of association. For a given biological group, if
the miRNA/mRNA is DE and overexpressed (with respect to
reference), then it is assigned the value 1. Similarly, if the miRNA/
mRNA is DE and underexpressed, then it is assigned the value
21. Finally, if the miRNA/mRNA is not DE, then it is assigned
the value 0. We denote the total number of biological groups
(excluding the reference) as C. Therefore, for every miRNA/
mRNA, we obtain a vector of C discrete values. The discretized
data are used to populate the 363 contingency table (Table 3)
shown below.
Here, a11 corresponds to the number of biological groups where
both miRNA and mRNA are underexpressed with respect to
reference. We use a and b to denote the miRNA and mRNA of
interest, respectively, and a:b to denote the miRNA-
mRNA pair. Therefore, for miRNA a and mRNA b,
a11~
P C
i~1
I(ai~{1)|I(bi~{1), where I is an indicator function
that takes the values 1 if the condition is satisfied and 0, otherwise.
Similarly, we obtain a12–a33.
(ii) Significance of association. Once the 363 contingency
table has been populated for a given miRNA-mRNA pair, we
calculate the probability of obtaining the observed set of nine
values (a11,…,a33) by chance. To determine this probability, we
assume that the nine values are obtained from a multinomial
distribution and that there is no biological association between a
and b.
Given that every mRNA has C discrete values (corresponding to
the C biological groups), firstly, we obtain a matrix W1 comprising
Z rows and C columns, where Z denotes the number of mRNAs.
Secondly, we jumble the rows and columns of W1 to obtain a new
Table 2. Association measures for co-analysis of miRNA and mRNA expression profiles.
Number of conditions
Two Large
Expression profiles Matched MD association measure Correlation coefficient
Unmatched 2 UD association measure
doi:10.1371/journal.pone.0029612.t002
Table 3. Generic table for measuring association between a
miRNA-mRNA pair using unmatched data.
mRNA
210 1
miRNA 21 a11 a12 a13
0 a21 a22 a23
1 a31 a32 a33
doi:10.1371/journal.pone.0029612.t003
Association Measure for Unmatched and Matched Data
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selected at random from the Z6C values in W1. Thirdly, we
sample with replacement the rows from matrix W2 and obtain the
matrix W3. The number of times the sampling is performed, i.e.
Nrep, is user-defined and, in this paper, all results were obtained
using Nrep=10000. The matrix W3 comprises 10000 pseudo-
mRNAs that have no genuine association to the miRNA a.
Finally, we populate the 363 contingency table (Table 2) using the
discretized values for miRNA a and the Nrep pseudo-mRNAs. We
obtain the average values for the 9 elements a11,…,a33 by dividing
the values in the contingency table by Nrep. These average values
represent the probabilities for the nine elements under the
assumption that there is no biological association between the
miRNA a and an mRNA. We provide these probabilities as input
to the R [50] package EMT and determine the p-value, for the
observed association between miRNA a and its putative target b,
using a multinomial distribution. Instead of a test based on
multinomial distribution, a x
2-test can be performed if the number
of conditions is large (.15).
(iii) miRNA-mRNA pairs of interest. A miRNA a is
predicted to target several mRNAs and the test of significance
described above has to be performed for all the targets of a. Since
miRNAs are negative regulators of mRNA expression, the change
in the expression of a genuine target must be in the opposite
direction to that for the miRNA. Therefore, instead of evaluating
all the predicted targets of a, we only consider those targets which
have an opposite direction of change (with respect to a) in at least
one of the C biological groups. We adjust the p-values (returned by
the test of significance) for multiple comparisons using the
Benjamini-Hochberg (BH) correction [33]. We consider a
miRNA-mRNA pair to be significant if the adjusted p-value is
less than 0.05.
Matched data
We now describe the method for the identification of significant
miRNA-mRNA pairs using expression data that are matched but
correspond to just two conditions. Firstly, we select the samples
corresponding to one of the conditions as the reference, e.g. in an
analysis involving a MM group and healthy donors, the latter may
be selected as the reference. Secondly, we model the change in
mRNA expression as a function of the change in miRNA
expression and obtain the statistical significance of association
for the miRNA-mRNA pair. The actual steps are described in
detail below:
(i) Measure of associatio. Let the number of healthy donors
and MM samples be Nref and Nbiol, respectively. Typically,
Nref%Nbiol, e.g. the Gutierrez data set had 14 MM samples with
RB deletion and just three healthy donors, and our measure of
association focuses on such cases. Let m and u denote the median
mRNA and miRNA expression values, respectively, for the
healthy donors. We consider the median values instead of
average values because the former are not sensitive to the
presence of outliers. Let l denote the change in mRNA expression
owing to a unit change in miRNA expression. Let xi and yi denote
the miRNA and mRNA expressions, respectively, for the i
th MM
sample. Now, we model the relationship between miRNA and
mRNA expression in MM samples as follows:
yi~mzl(xi{u),
where 1#i#Nbiol
or
yi{m~l(xi{u): ð1Þ
For two-channel experiments, every microarray slide contains the
expression profile of a MM sample and healthy donor. Therefore,
we directly obtain the CE-values, i.e. yi2m for mRNAs and xi2u
for miRNAs. In contrast, for single-channel experiments, a
microarray slide corresponds to the expression profile of a healthy
donor or MM sample and the CE-values have to be obtained
explicitly.
(ii) Significance of association. Once the value of l has
been estimated using Equation (1), the next step is to ascertain its
statistical significance. Specifically, if a miRNA-mRNA pair is
genuine, then the change in miRNA expression must produce a
change in mRNA expression which is higher than that obtained by
chance. We achieve this by performing a permutation test similar
to that described earlier for the identification of significant
miRNA-mRNA pairs using unmatched data.
Let Q1 denote the matrix of Z rows (corresponding to Z
mRNAs) and Nbiol columns. Next, we jumble the rows and
columns of Q1, in a manner similar to that described for UD, and
obtain a new matrix Q2. We sample with replacement the rows
from matrix Q2 and obtain the matrix Q3. The sampling is
performed Nrep times and each sample represents a pseudo-
mRNA with no genuine association to miRNA a.
We use Equation (1) to estimate l for the association between
miRNA a and every pseudo-mRNA in Q3. These values of l
represent the null distribution, i.e. the distribution when miRNA a
and an mRNA do not have a biological association. If the a:b pair
is biologically important, then the observed value of l (i.e. l
obs)
must be negative (implying a negative regulation of the mRNA by
a) and smaller than the values in the null distribution. Therefore,
the p-value is obtained as Pr(l#l
obs).
(iii) miRNA-mRNA pairs of interest. For a given miRNA
a, we first identify all the predicted targets that have an average
CE-value in the opposite direction to that for the miRNA. Next,
we obtain the p-values using the test of significance described
above. Finally, we adjust the p-values for multiple comparisons
using the BH correction. We consider a miRNA-mRNA pair to be
significant if l
obs is negative and the adjusted p-value is less than
0.05.
Biological data sets
We considered two publicly available data sets – Gutierrez data
set [24] and Lionetti data set [20]. The Gutierrez data set
comprised five healthy donors and 55 MM patients that were
stratified into four groups – normal FISH, t(11:14), t(4;14) and RB
deletion. The raw miRNA and mRNA expression values were
downloaded from Gene Expresssion Omnibus (GEO) accession
number GSE16558. The miRNA expression profiles were
obtained using TaqMan low-density arrays and normalized using
the mean of RNU44 and RNU48, as suggested by the authors
[24]. The mRNA expression profiles were obtained using
Affymetrix Human Gene 1.0 ST arrays and the preprocessing
steps included RMA background correction [51], quantile
normalization [52] and summarization of mRNA expression
using the median polish algorithm. The Lionetti data set contained
40 MM patients (stratified into five groups based on TC
classification), three healthy donors for miRNAs, and four healthy
donors for mRNAs. The normalized miRNA and mRNA
expression values (Figure S1) were downloaded from GEO
accession numbers GSE17498 and GSE13591, respectively.
For each data set, we tested the null hypothesis that the average
expression of a miRNA/mRNA in a MM group was the same as
that for healthy donors. We adjusted the p-values (corresponding
to the tests of hypotheses) for multiple comparisons using the BH
method. We considered a miRNA/mRNA to be DE if the
Association Measure for Unmatched and Matched Data
PLoS ONE | www.plosone.org 8 January 2012 | Volume 7 | Issue 1 | e29612difference in average expression was greater than 1.5 and the
adjusted p-value was less than 0.05.
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